COVID-19 Testing Drives 80 Percent Growth in GenMark Diagnostics Preliminary Q1 Revenues

Apr 07, 2020

|

NEW YORK – GenMark Diagnostics said after the close of the market on Tuesday that it expects to report total revenues of $38.7 million for the first quarter of 2020, up 80 percent from $21.5 million in Q1 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Slow Release of Viral Sequence

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

Journals Raise Concerns Over Data Source

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports.

Details From a Short Life

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

Genome Research Papers on Brain Expression, Inversion Assay, Polymorphic Yeast Centromeres

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.

Menu

COVID-19 Testing Drives 80 Percent Growth in GenMark Diagnostics Preliminary Q1 Revenues

To read the full story....

Breaking News

Sperm Single Cell Sequencing Study Offers Insight Into Meiotic Variation

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

OpGen Expands Partnership with New York State Department of Health to Detect AMR Infections

OraSure Technologies Prices $82.5M Stock Offering

PharmaFluidics Wins €613K Grant From Flemish Government

NuProbe Licenses Two Oligonucleotide Technologies from Rice University

The Scan

Slow Release of Viral Sequence

Journals Raise Concerns Over Data Source

Details From a Short Life

Genome Research Papers on Brain Expression, Inversion Assay, Polymorphic Yeast Centromeres

What's Popular?

Guardant Health Prices $315M Public Offering

10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods

Seven Bridges Joins International Genomic Cancer Research Effort

Personalis, Sarepta Therapeutics Exploring Immune Response to Precision Genetic Therapeutics

NuProbe Licenses Two Oligonucleotide Technologies from Rice University

Sponsorships